35202-55-2

35202-55-2 - Names and Identifiers

Name	(3,4-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methanamine hydrochloride
Synonyms	(3,4-dimethoxy-7-bicyclo[4.2.0]octa-1,3,5-trienyl)methanamine (3,4-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methanamine hydrochloride
CAS	35202-55-2

35202-55-2 - Physico-chemical Properties

Molecular Formula	C11H16ClNO2
Molar Mass	229.70
Storage Condition	Sealed in dry,Room Temperature
MDL	MFCD28038688

35202-55-2 - Upstream Downstream Industry

Raw Materials

(E)-3-(3,4-dimethoxyphenyl)acrylonitrile
3-(3,4-Dimethoxyphenyl)propanenitrile
4,5-Dimethoxy-1-cyanobenzocyclobutane
3-(2-BROMO-4,5-DIMETHOXYPHENYL)PROPANENITRILE
2-Bromo-4,5-Dimethoxybenzyl Bromide
4-Bromoveratrole
3,4-Dimethoxybenzyl alcohol
Veratraldehyde

35202-55-2 - Introduction

(3,4-dimethoxybicyclo [4.2.0]octa-1,3,5-trien-7-yl)methanamine hydrochloride is an organic compound with the chemical formula C12H17NO2 · HCl.

Nature:
The compound was a white crystalline solid. It is a bicyclic compound with two methoxy groups and has a helical structure. It is relatively stable at room temperature and soluble in water and organic solvents.

Use:
(3,4-dimethoxybicyclo [4.2.0]octa-1,3,5-trien-7-yl)methanamine hydrochloride is used as an intermediate in the pharmaceutical field and can be used to synthesize other drugs or compounds. It is also used as a reducing agent and catalyst in organic synthesis.

Method:
(3,4-dimethoxybicyclo [4.2.0]octa-1,3,5-trien-7-yl)methanamine hydrochloride can be synthesized by multi-step reaction. A common synthetic method involves reacting the appropriate compound with methylamine, followed by a cyclization reaction and finally with hydrochloric acid.

Safety Information:
The compound is generally safe under normal conditions of use. However, as a chemical substance, it is still necessary to follow the general laboratory safety procedures. Take care to avoid direct contact with skin and eyes, and maintain a well-ventilated laboratory environment. The relevant safety data sheets should be read and followed prior to any use.

Last Update：2024-04-09 20:45:29